What is diindolylmethane?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Diindolylmethane (DIM)?

Diindolylmethane (DIM) is a bioactive compound formed from the acid-catalyzed breakdown of indole-3-carbinol found in cruciferous vegetables (broccoli, cauliflower, cabbage, brussels sprouts), available as a dietary supplement typically dosed at 150 mg per capsule, with demonstrated chemopreventive activities in breast cancer through modulation of estrogen metabolism. 1, 2, 3

Chemical Origin and Formation

  • DIM is synthesized after glycolysis from the glucosinolate structure in cruciferous vegetables, specifically through acid-catalyzed dimerization of indole-3-carbinol in the stomach 3
  • The compound represents one of several bioactive chemicals produced when cruciferous vegetables are consumed and digested 1
  • DIM has been documented to have chemopreventive activities in all stages of breast cancer carcinogenesis 1

Mechanism of Action

  • DIM binds to receptors associated with sex steroid pathways and has effects on estrogen and androgen physiology 4
  • The compound acts as a selective aryl hydrocarbon receptor modulator (SAhRM), binding to the aryl hydrocarbon receptor but exhibiting minimal CYP1A1 induction at therapeutic doses 5
  • DIM inhibits estrogen-induced cancer cell growth through modulation of estrogen-dependent and estrogen-independent pathways 3, 5

Clinical Applications and Evidence

  • Estrogen metabolism modulation: DIM increases the urinary 2/16α-hydroxyestrone ratio, a biomarker associated with reduced breast cancer risk 6
  • Sex hormone-binding globulin (SHBG): Clinical trials demonstrate DIM increases serum SHBG levels (+25 nmol/L vs +1.1 nmol/L with placebo), which may reduce bioavailable estrogen 6
  • Cancer prevention: Preclinical and clinical trials have evaluated DIM for cervical dysplasia, prostate cancer, and breast cancer prevention with promising results 3

Metabolism and Pharmacokinetics

  • Contrary to earlier studies, recent research demonstrates DIM undergoes significant phase 1 and phase 2 metabolism in humans 7
  • Monohydroxylated and dihydroxylated metabolites appear rapidly in plasma and urine, along with their sulfate and glucuronide conjugates 7
  • One metabolite, 3-((1H-indole-3-yl)methyl)indolin-2-one, exhibits greater potency as an aryl hydrocarbon receptor agonist than parent DIM 7
  • The compound can also serve as a urinary biomarker of glucobrassicin exposure and indole-3-carbinol uptake from Brassica vegetables 1

Critical Drug Interaction Warning

DIM significantly reduces plasma concentrations of tamoxifen metabolites (endoxifen, 4-OH tamoxifen, N-desmethyl-tamoxifen) when co-administered, which may attenuate tamoxifen's clinical benefit. 6

  • This interaction occurs despite DIM's favorable effects on estrogen metabolism markers 6
  • Patients taking tamoxifen should avoid DIM supplementation until further research clarifies whether the reduction in endoxifen levels compromises tamoxifen efficacy 6

Potential Safety Concerns

  • A case report documents possible association between DIM supplementation and venous thromboembolism (deep venous thrombosis and bilateral pulmonary embolism) in a 65-year-old man taking one tablet daily for 3-4 months 4
  • While this represents a single case with multiple confounding risk factors (tobacco use, prior PE history, elevated BMI, age), clinicians should question patients about DIM supplementation when evaluating venous thromboembolism 4
  • In controlled trials, minimal adverse events were reported and did not differ from placebo, with >91% compliance over 12 months 6

Pharmacologic Limitations

  • DIM faces challenges related to low solubility and poor bioavailability 3
  • Commercial formulations like BioResponse DIM® incorporate BioPerine® (black pepper extract) to enhance absorption 2
  • Standard supplement formulations contain 150 mg DIM per capsule, often combined with broccoli extract, calcium D-glucarate, and absorption enhancers 2

Dietary Context

  • Cruciferous vegetable intake of approximately 57 g/day (achievable through 5 servings/day of vegetables) provides protective amounts of DIM and related compounds against breast cancer recurrence 1
  • Concerns about goitrin from cruciferous vegetables interfering with thyroid function are not biologically plausible at conventional nutritional recommendations (≤50 g/day), and 150 g/day of cooked cruciferous vegetables for 4 weeks showed no effect on thyroid function 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.